(PAND) – Company Press Releases
-
Merck Completes Acquisition of Pandion Therapeutics
-
Merck Begins Tender Offer to Acquire Pandion Therapeutics
-
PANDION ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of PAND and Encourages Investors to Contact the Firm
-
Merck to Acquire Pandion Therapeutics
-
Pandion Therapeutics Presents Preclinical Data Highlighting Potential of Tissue-Tethered PD-1 Agonist to Locally Target Autoimmune Disease at the nPOD 13th Annual Scientific Meeting
-
Pandion Therapeutics Presents Preclinical Data Highlighting Potential of Tissue-Tethered PD-1 Agonist to Locally Target Autoimmune Disease at the nPOD 13th Annual Scientific Meeting
-
Pandion Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
-
Pandion Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
-
Pandion Therapeutics Announces Positive Top-Line Phase 1a Clinical Data Showing PT101 was Well-Tolerated and Selectively Expanded Regulatory T cells
-
Pandion Therapeutics Announces Positive Top-Line Phase 1a Clinical Data Showing PT101 was Well-Tolerated and Selectively Expanded Regulatory T cells
-
NodThera Appoints Chief Medical Officer and Chief Financial Officer
-
Pandion Therapeutics Appoints Katina Dorton to its Board of Directors
-
Pandion Therapeutics Appoints Katina Dorton to its Board of Directors
-
Pandion Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
-
Pandion Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
-
Pandion Therapeutics to Present at the Stifel 2020 Virtual Healthcare Conference
-
Pandion Therapeutics to Present at the Stifel 2020 Virtual Healthcare Conference
-
Pandion Therapeutics Highlights Potential of Modular Biologics Pipeline for the Treatment of Autoimmune Diseases at FOCIS 2020
-
Pandion Therapeutics Highlights Potential of Modular Biologics Pipeline for the Treatment of Autoimmune Diseases at FOCIS 2020
-
Pandion Therapeutics to Participate in Panel Discussion at Stifel 2020 Immunology & Inflammation Virtual Summit
-
Pandion Therapeutics to Participate in Panel Discussion at Stifel 2020 Immunology & Inflammation Virtual Summit
-
Pandion Therapeutics to Present at Morgan Stanley Global Healthcare Conference
-
Pandion Therapeutics to Present at Morgan Stanley Global Healthcare Conference
-
Pandion Reports Second Quarter 2020 Financial Results and Provides Business Update
-
Pandion Reports Second Quarter 2020 Financial Results and Provides Business Update
-
Pandion Therapeutics Announces Pricing of Initial Public Offering
-
Pandion Therapeutics Announces Pricing of Initial Public Offering
Back to PAND Stock Lookup